How To Buy LinkedIn Below Its IPO Price

It’s official, you were able to agree to purchase LinkedIn BELOW its IPO price after the IPO.  The magic of the market through which this can occur is the much maligned derivative instrument, more specifically in this case, the short put.

During the first day of options trading, LinkedIn put options were trading with implied volatility levels twice the level of equivalent call options.  The implication from the inflated prices was that the market was placing greater likelihood on LinkedIn falling in price than on it rising.

One cause for this expectation is that limited supply of stock was available to borrow and short, leaving put instruments as the only viable alternative by which to benefit from a decline in stock price.  Another cause is that the supply of shares which can be sold following the lock-up period is over twice the current float, which should inevitably lead to downward price pressure.

But the lock-up period should be very closely examined by traders feeling comfortable that the stock has greater forces of demand than supply until that date.  The option prices provide a clue into why traders should look at the fine print to see why this is a dangerous assumption to make.

The implied volatility on the put options isn’t just high for one month or two months or even three but it remains high all the way out until February of 2012.  That suggests tremendous uncertainty in the market about when the stock might suffer from the supply of shares coming online.  The question is why is the market so uncertain?

Looking at the fine print, the decision to release further shares onto the market is at the sole discretion of the underwriter, Morgan Stanley.  They could choose to release shares earlier than the anticipated lock-up period or indeed later!  That leads to tremendous uncertainty in the market place.

It also offers traders a chance to capitalize on exceedingly high put premiums.  And not necessarily by buying them but potentially by selling them.  For example, a short put at strike 50 in Feb 2012 was selling at $5.20 on the opening day’s trading.  That meant a trader could get paid $5.20 to agree to purchase the stock at $50 next February in the event that the stock was trading below $50.  In effect, traders were agreeing to purchase the stock at a price of $44.80 ($50-$5.20), which is below the IPO price.

Often selling the premiums that soar during moments of excess can be very lucrative in the long-term.  These opportunities don’t come along often but when they do, the reward to risk ratio can prove very compelling.

Be Sociable, Share!

Related Posts


MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.

This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.

The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The educational training program and software services are provided to improve financial understanding.

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.